Transforming growth factor-beta (tgf) signaling pathway in cholangiocarcinoma

HIGHLIGHTS

  • who: Panagiotis Papoutsoglou and collaborators from the , Rennes, France have published the Article: Transforming Growth Factor-Beta (TGF) Signaling Pathway in Cholangiocarcinoma, in the Journal: (JOURNAL)
  • what: The authors provide an overview of the physiological functions of signaling in preserving liver homeostasis and describe how advanced cholangiocarcinoma benefits from the tumor-promoting effects of Moreover the authors report the importance of noncoding RNAs as effector molecules downstream of during cholangiocarcinoma progression and conclude by highlighting the need for identifying novel and clinically relevant biomarkers for a better management of patients with cholangiocarcinoma.

SUMMARY . . .

 

Logo ScioWire Beta black

If you want to have access to all the content you need to log in!

Thanks :)

If you don't have an account, you can create one here.

 

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?